A citation-based method for searching scientific literature

Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, G Alexander Fleming, Loukas Gourgiotis, Mala Puri, Li-Jung Tai, J Rick Turner. Curr Diabetes Rev 2017
Times Cited: 7







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.
Mirela Delibegovic, Derek Zimmer, Caitlin Kauffman, Kimberly Rak, Eun-Gyoung Hong, You-Ree Cho, Jason K Kim, Barbara B Kahn, Benjamin G Neel, Kendra K Bence. Diabetes 2009
187
14

Myeloid-cell protein tyrosine phosphatase-1B deficiency in mice protects against high-fat diet and lipopolysaccharide-induced inflammation, hyperinsulinemia, and endotoxemia through an IL-10 STAT3-dependent mechanism.
Louise Grant, Kirsty D Shearer, Alicja Czopek, Emma K Lees, Carl Owen, Abdelali Agouni, James Workman, Cristina Martin-Granados, John V Forrester, Heather M Wilson,[...]. Diabetes 2014
48
14

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice.
Bradley A Zinker, Cristina M Rondinone, James M Trevillyan, Rebecca J Gum, Jill E Clampit, Jeffrey F Waring, Nancy Xie, Denise Wilcox, Peer Jacobson, Leigh Frost,[...]. Proc Natl Acad Sci U S A 2002
326
14


Protein tyrosine phosphatase 1B interacts with the activated insulin receptor.
B L Seely, P A Staubs, D R Reichart, P Berhanu, K L Milarski, A R Saltiel, J Kusari, J M Olefsky. Diabetes 1996
244
14



Target-based drug discovery: is something wrong?
Frank Sams-Dodd. Drug Discov Today 2005
309
14

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice.
L D Klaman, O Boss, O D Peroni, J K Kim, J L Martino, J M Zabolotny, N Moghal, M Lubkin, Y B Kim, A H Sharpe,[...]. Mol Cell Biol 2000
961
14

Animal research: reporting in vivo experiments: the ARRIVE guidelines.
Carol Kilkenny, William Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman. Br J Pharmacol 2010
14

Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis.
Cristina M Rondinone, James M Trevillyan, Jill Clampit, Rebecca J Gum, Cathy Berg, Paul Kroeger, Leigh Frost, Bradley A Zinker, Regina Reilly, Roger Ulrich,[...]. Diabetes 2002
120
14

Diabetes mellitus and oxidative stress-A concise review.
Ullah Asmat, Khan Abad, Khan Ismail. Saudi Pharm J 2016
367
14

Dyslipidemia in diabetes mellitus.
G Yoshino, T Hirano, T Kazumi. Diabetes Res Clin Pract 1996
37
14


Diabetic dyslipidemia.
Marja-Riitta Taskinen. Atheroscler Suppl 2002
120
14

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.
R J Koenig, C M Peterson, R L Jones, C Saudek, M Lehrman, A Cerami. N Engl J Med 1976
14


THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors.
Stephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, Neil V Marrion, John A Peters, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan,[...]. Br J Pharmacol 2017
172
14

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.
Stephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, Neil V Marrion, John A Peters, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan,[...]. Br J Pharmacol 2017
578
14

Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.
C Owen, E K Lees, L Grant, D J Zimmer, N Mody, K K Bence, M Delibegović. Diabetologia 2013
43
14

Structural and evolutionary relationships among protein tyrosine phosphatase domains.
J N Andersen, O H Mortensen, G H Peters, P G Drake, L F Iversen, O H Olsen, P G Jansen, H S Andersen, N K Tonks, N P Møller. Mol Cell Biol 2001
517
14

Bromocriptine for diabetes mellitus type II.
Guy Valiquette. Cardiol Rev 2011
9
14

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.
M Elchebly, P Payette, E Michaliszyn, W Cromlish, S Collins, A L Loy, D Normandin, A Cheng, J Himms-Hagen, C C Chan,[...]. Science 1999
14


Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B.
Hanying Ding, Yan Zhang, Chen Xu, Dongxia Hou, Jing Li, Yujing Zhang, Wei Peng, Ke Zen, Chen-Yu Zhang, Xiaohong Jiang. Diabetologia 2014
23
14

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.
Christopher Southan, Joanna L Sharman, Helen E Benson, Elena Faccenda, Adam J Pawson, Stephen P H Alexander, O Peter Buneman, Anthony P Davenport, John C McGrath, John A Peters,[...]. Nucleic Acids Res 2016
951
14

Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice.
Fawaz G Haj, Janice M Zabolotny, Young-Bum Kim, Barbara B Kahn, Benjamin G Neel. J Biol Chem 2005
95
14

Protein tyrosine phosphatase 1B inhibitors for diabetes.
Theodore O Johnson, Jacques Ermolieff, Michael R Jirousek. Nat Rev Drug Discov 2002
416
14


Experimental design and analysis and their reporting: new guidance for publication in BJP.
Michael J Curtis, Richard A Bond, Domenico Spina, Amrita Ahluwalia, Stephen P A Alexander, Mark A Giembycz, Annette Gilchrist, Daniel Hoyer, Paul A Insel, Angelo A Izzo,[...]. Br J Pharmacol 2015
845
14

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes.
Katrina MacAulay, James R Woodgett. Expert Opin Ther Targets 2008
62
14

Type 2 diabetes mellitus: a review of current trends.
Abdulfatai B Olokoba, Olusegun A Obateru, Lateefat B Olokoba. Oman Med J 2012
350
14

A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance.
Xiaolin Zhang, Jinying Tian, Juan Li, Liwei Huang, Song Wu, Wei Liang, Liangwei Zhong, Jianping Ye, Fei Ye. Br J Pharmacol 2016
13
14

Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
S Fukuda, T Ohta, S Sakata, H Morinaga, M Ito, Y Nakagawa, M Tanaka, M Matsushita. Diabetes Obes Metab 2010
37
14

Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.
Jiao Luo, Qi Xu, Bo Jiang, Renshuai Zhang, Xiaoling Jia, Xiangqian Li, Lijun Wang, Chuanlong Guo, Ning Wu, Dayong Shi. Br J Pharmacol 2018
18
14

Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B.
Mirela Delibegovic, Kendra K Bence, Nimesh Mody, Eun-Gyoung Hong, Hwi Jin Ko, Jason K Kim, Barbara B Kahn, Benjamin G Neel. Mol Cell Biol 2007
114
14




Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
Françoise Bono, Frederik De Smet, Corentin Herbert, Katrien De Bock, Maria Georgiadou, Pierre Fons, Marc Tjwa, Chantal Alcouffe, Annelii Ny, Marc Bianciotto,[...]. Cancer Cell 2013
93
14

Endogenous retroviruses and human disease.
Antonina Dolei. Expert Rev Clin Immunol 2006
24
14

The discovery of endogenous retroviruses.
Robin A Weiss. Retrovirology 2006
186
14

Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus.
Hannu Juvonen, Antti Reunanen, Jari Haukka, Maria Muhonen, Jaana Suvisaari, Ritva Arajärvi, Timo Partonen, Jouko Lönnqvist. Arch Gen Psychiatry 2007
34
14


The co-occurrence of multiple sclerosis and type 1 diabetes: shared aetiologic features and clinical implication for MS aetiology.
Prudence Tettey, Steve Simpson, Bruce V Taylor, Ingrid A F van der Mei. J Neurol Sci 2015
21
14

The enemy within: endogenous retroelements and autoimmune disease.
Hannah E Volkman, Daniel B Stetson. Nat Immunol 2014
150
14

Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.
Emma L Smith, Mark Peakman. Front Immunol 2018
24
14

Infection as a cause of type 1 diabetes?
Urs Christen, Christine Bender, Matthias G von Herrath. Curr Opin Rheumatol 2012
32
14

Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells.
M Vives-Pi, N Somoza, J Fernández-Alvarez, F Vargas, P Caro, A Alba, R Gomis, M O Labeta, R Pujol-Borrell. Clin Exp Immunol 2003
116
14

An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.
Sandrine Levet, Julie Medina, Julie Joanou, Amandine Demolder, Nelly Queruel, Kevin Réant, Matthieu Normand, Marine Seffals, Julie Dimier, Raphaële Germi,[...]. JCI Insight 2017
30
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.